Product Information
CROMOLYN 4% EYE DROPS is a generic product labeled by Sandoz Inc., priced at $0.5953 per ML under NDC 61314023710. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 16, 1999.
Strength
40 mg/mL
Manufacturer
Sandoz Inc.NDC
61314023710
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
CROMOLYN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA075282FDA Approved
6/16/1999
On Market Since
6/29/1999
Pharmacological Classes
Price Statistics
The NADAC for CROMOLYN 4% EYE DROPS has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 15.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5953 per ML |
|---|---|
| All-time high | $0.8610 (Mar 10, 2021) |
| All-time low | $0.4733 (Dec 19, 2018) |
| 52-week high | $0.6009 |
| 52-week low | $0.5669 |
| Median price | $0.5522 |
| Average price | $0.5657 |
| Largest weekly change | +36.0% (Jul 22, 2020) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Cromolyn Sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cromolyn Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Mast Cell Stabilizer class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CROMOLYN 4% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for CROMOLYN 4% EYE DROPS, manufactured by Sandoz Inc., is $0.5953 per ML (NDC 61314023710), effective Sep 30, 2026.
How has the price of CROMOLYN 4% EYE DROPS changed over time?
Over the history we have for it, the NADAC for CROMOLYN 4% EYE DROPS has risen 15.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CROMOLYN 4% EYE DROPS?
Since Nov 28, 2013, the NADAC for CROMOLYN 4% EYE DROPS has ranged from a low of $0.4733 (Dec 19, 2018) to a high of $0.8610 (Mar 10, 2021), with a median of $0.5522 per ML.
Are there cheaper alternatives to CROMOLYN 4% EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of CROMOLYN 4% EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CROMOLYN 4% EYE DROPS?
CROMOLYN 4% EYE DROPS (NDC 61314023710) is labeled by Sandoz Inc., and CMS classifies it as a generic product.